Q1 2020 Holdings
Filed 2020-05-15 | 90 holdings | $590.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adapthealth Corp(AHCO) | COM CL A | 00653Q102 | $275.2M | 17,199,888 | 46.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $75.3M | 1,267,206 | 12.7% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $57.4M | 18,402,355 | 9.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $48.9M | 1,212,922 | 8.3% |
| Alector Inc(ALEC) | COM | 014442107 | $42.0M | 1,738,997 | 7.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $20.0M | 151,779 | 3.4% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $17.5M | 3,083,000 | 3.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $13.4M | 536,001 | 2.3% |
| Cerus Corp(CERS) | COM | 157085101 | $10.3M | 2,204,700 | 1.7% |
| Axogen Inc(AXGN) | COM | 05463X106 | $9.8M | 937,983 | 1.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $9.4M | 1,284,313 | 1.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.3M | 4,652,926 | 1.6% |
| Mylan N V | SHS EURO | N59465109 | $181.2K | 12,151,362 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $174.4K | 5,888,511 | 0.0% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $168.7K | $144,832,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $133.9K | $115,776,000 | 0.0% |
| DFP Healthcare Acquisitns Co | UNIT 03/31/2025 | 23343Q209 | $103.0K | 10,460,000 | 0.0% |
| Nuvasive Inc | NOTE 2.250% 3/1 | 670704AG0 | $88.7K | $85,000,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $66.7K | 8,862,247 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $62.7K | 4,037,305 | 0.0% |
| Dexcom Inc | NOTE 0.750%12/0 | 252131AH0 | $58.9K | $34,000,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $58.0K | 1,346,167 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $55.4K | 4,107,464 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $54.6K | 376,000 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $54.6K | 1,627,521 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $50.9K | $61,000,000 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $48.3K | 3,448,912 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $46.8K | $57,791,000 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $46.1K | 3,031,565 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $45.6K | 1,794,594 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $43.6K | $49,064,000 | 0.0% |
| Silk RD MED Inc | COM | 82710M100 | $42.4K | 1,348,000 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $40.8K | 4,447,109 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $39.4K | 1,796,383 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $39.3K | 1,316,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $35.9K | 1,616,993 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $34.2K | 2,532,147 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $32.7K | 2,758,267 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $30.8K | 343,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $30.1K | 3,253,960 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $30.0K | 954,100 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $26.9K | $24,877,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.8K | 457,968 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $26.6K | 412,867 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $26.5K | 183,865 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $24.3K | 589,485 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $23.7K | 175,437 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $23.4K | 6,184,243 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $23.4K | 87,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.4K | 1,677,367 | 0.0% |